• Text size
  • A
  • A
  • A
**We are still available during the COVID-19 outbreak but we may take a little longer to get back to you**
menu

Shielding for those who are Clinically Extremely Vulnerable – until 31st March 2021

17/02/2021

You may have heard on the news that a further 1.7m people have been added to the 2.2m list of people asked to shield (clinically extremely vulnerable) in the UK as a result of the COVID-19 new strain.  People with the following conditions are automatically deemed clinically extremely vulnerable:

  • solid organ transplant recipients
  • people with specific cancers:
    • people with cancer who are undergoing active chemotherapy
    • people with lung cancer who are undergoing radical radiotherapy
    • people with cancers of the blood or bone marrow such as leukaemia, lymphoma or myeloma who are at any stage of treatment
    • people having immunotherapy or other continuing antibody treatments for cancer
    • people having other targeted cancer treatments that can affect the immune system, such as protein kinase inhibitors or PARP inhibitors
    • people who have had bone marrow or stem cell transplants in the last 6 months or who are still taking immunosuppression drugs
  • people with severe respiratory conditions including all cystic fibrosis, severe asthma and severe chronic obstructive pulmonary disease (COPD)
  • people with rare diseases that significantly increase the risk of infections (such as severe combined immunodeficiency (SCID), homozygous sickle cell disease)
  • people on immunosuppression therapies sufficient to significantly increase risk of infection
  • problems with your spleen, for example splenectomy (having your spleen removed)
  • adults with Down’s syndrome
  • adults on dialysis or with chronic kidney disease (stage 5)
  • women who are pregnant with significant heart disease, congenital or acquired
  • other people who have also been classed as clinically extremely vulnerable, based on clinical judgement and an assessment of their needs. GPs and hospital clinicians have been provided with guidance to support these decisions

 There are 3 ways you may be identified as clinically extremely vulnerable:

  1. You have one or more of the conditions listed above;
  2. Your clinician or GP has added you to the Shielded Patient List because, based on their clinical judgement, they deem you to be at high risk of serious illness if you catch the virus; or
  3. You have been identified through the COVID-19 Population Risk Assessment as potentially being at high risk of serious illness if you catch the virus.

 If you have been shielding in the past you should assume that you are clinically vulnerable and shield, if you receive a letter, email or text from the NHS advising you that you now fall into the new risk categories, you should shield.  Shielding will be in place until 31st March 2021. 

Recent



           Volunteering             


Receive our newsletter